Overexpression of the mutationally activated Xmrk receptor initiates the formation of hereditary malignant melanoma in the ®sh Xiphophorus. In addition to transcriptional overexpression a cell-type speci®c signal transduction is essential for Xmrk mediated tumor formation. To elucidate the consequence of Xmrk signalling and to identify target proteins that characterize the tumor phenotype, we analysed proteins that are strongly tyrosine phosphorylated in the ®sh melanoma cell line PSM. One of the most prominent phosphotyrosine proteins was found to be the signal transducer and activator of transcription STAT5. In a heterologous cell system (murine pro B-cells), activation of the Xmrk kinase in a chimeric receptor induced tyrosine phosphorylation, nuclear translocation and DNA binding of STAT5. Following receptor stimulation, expression of the STAT5 speci®c target genes cis, osm and pim-1 was induced. In Xiphophorus PSM cells STAT5 was found to be preferentially localized in the nucleus, but treatment with tyrphostin AG555, a speci®c Xmrk kinase-inhibitor, blocked nuclear localization. In these cells as well as in Xiphophorus melanoma expression of pim-1 and constitutive DNA-binding activity of STAT5 was detectable. This constitutive activity was higher in malignant than in benign melanomas, indicating that STAT5 activation is correlated with the malignancy of these tumors.
Introduction
Receptor tyrosine kinases (RTKs) play a major role in tumor development where in many cases they are overexpressed. In the ®sh Xiphophorus, high expression of the RTK Xmrk (Xiphophorus melanoma receptor kinase) is responsible for the formation of malignant melanoma (Schartl, 1995) . There is a positive correlation between its expression level and the malignancy of the tumors (MaÈ ueler et al., 1993) . The Xmrk protein belongs to the family of epidermal growth factor receptors (EGFRs) and its gene is present in the ®sh genome additionally to the Xiphophorus EGFR (Wittbrodt et al., 1989, A GoÂ mez, unpublished) . So far its functional mammalian homologue has not been identi®ed. In a cell line that was established from Xiphophorus melanoma (PSM cells), the highly expressed Xmrk kinase shows a strong tyrosine phosphorylation indicating constitutive activation of the receptor (Malitschek et al., 1994) . Since the natural ligand of Xmrk is not known, inducible signalling exerted by the cytoplasmic domain of Xmrk has been studied using a chimeric receptor consisting of the extracellular part of the human EGFR (HER) and the intracellular part of Xmrk. Stimulation of this HER-mrk chimera, when expressed in NIH3T3 cells, results in receptor autophosphorylation and cell transformation (Wittbrodt et al., 1992) .
Although the ®rst cell speci®c event in tumor formation is the high expression of the oncogenic Xmrk gene exclusively in melanoma cells, experiments in Xmrk transgenic ®sh clearly showed that the Xmrk mediated intracellular signalling is involved in the celltype speci®c manifestation of the transformed state (Winkler et al., 1994) . In the Xiphophorus melanoma cell line PSM, which overexpresses Xmrk, the degree of tyrosine phosphorylation of several cellular proteins is remarkably high, obviously as a result of constitutive receptor activation. Thus, these phosphorylated proteins represent putative substrates of the Xmrk kinase. One of the substrates that seems to play a role in a Xmrk speci®c signal transduction is the cytoplasmic kinase fyn. The tyrosine phosphorylated receptor was found to be physically associated with p59 fyn in Xiphophorus PSM cells. Remarkably, in these cells the fyn kinase activity is extremely high, due to activation through Xmrk (Wellbrock et al., 1995) . Malignant melanomas also exhibit an elevated level of fyn kinase activity, which is about six times higher compared to benign tumors. However, nothing is known about nuclear events in the signalling of Xmrk.
For the EGFR it was shown that receptor stimulation results in tyrosine phosphorylation and activation of several members of the STAT (signal transducers and activators of transcription) family. These cytoplasmic proteins dimerize after tyrosine phosphorylation and, as a consequence, translocate to the nucleus, where they act as transcription factors. STAT1a, initially identi®ed as p91, was the ®rst STAT protein which was found to interact with the EGFR (Fu and Zhang, 1993) . STAT3 becomes also activated in response to EGF, an event which can lead to formation of STAT3 homodimers as well as to heterodimerization of STAT3 with STAT1a (Zhong et al., 1994) . Recently, STAT5, originally described as a prolactin responsive transcription factor in mammary gland epithelium , was found to be also involved in signalling pathways triggered by RTKs. Injection of EGF into mice caused tyrosine phosphorylation and speci®c DNA-binding of STAT5 in liver (Ru-Jamison et al., 1995) . Both, EGF and PDGF mediated STAT5 tyrosine phosphorylation was detected in ®broblasts expressing the respective receptors (David et al., 1996; Vignais et al., 1996) . However, apart from its activation through RTKs, STAT5 is playing its major role in signal transduction of the prolactin receptor and other cytokine receptors such as the IL-2-, IL-3-, the growth hormone and the erythropoietin (Epo) receptor in a variety of dierent cell types Gaen et al., 1995; Lin et al., 1996; Pallard et al., 1995; Xu et al., 1996) . Some reports have attributed to STAT5 functions in cell proliferation (Mui et al., 1996) , whereas in other cell systems STAT5 was described to participate in cell dierentiation (Mellitzer et al., 1996) .
The fact that STAT5 activity is controlled by this wide range of cytokines and growth factors suggests an important role of this protein in the regulation of cell dierentiation and cell growth. However, not much is known about STAT5 in tumor development. Recent data describe a constitutive activity of STAT proteins in cells from bcr ± abl kinase induced chronic myelogenous leukemia patients (Danial et al., 1995; Shuai et al., 1996) and in src transformed cells (Yu et al., 1995; Cao et al., 1996) . In HTLV-I-transformed T cells STAT5, together with STAT3, is constitutively activated coinciding with IL-2-independent growth of these cells (Migone et al., 1995) .
We have found that STAT5 is constitutively tyrosine phosphorylated and activated in hereditary melanomas of the ®sh Xiphophorus. Profound STAT5 activity was also observed in a melanoma derived cell line which expresses the RTK Xmrk in an activated form. In these cells STAT5 was found to be preferentially localized in the nucleus, but treatment with tyrphostin AG555, a speci®c Xmrk kinase-inhibitor, blocked nuclear localization. In the murine pro B-cell line Ba/F3, stably transfected with a chimeric Xmrk receptor, activation of the Xmrk kinase induced the tyrosine phosphorylation, nuclear translocation and DNA binding of STAT5 followed by induction of the STAT5 target genes cis, pim-1 and osm. Pim-1 was found to be also expressed in a ®sh melanoma cell line as well as in melanoma tissue. Interestingly, STAT5 activity was found to be much higher in malignant melanoma compared to that in benign.
Results

STAT5 is tyrosine phosphorylated in cells expressing an activated Xmrk kinase
A characteristic phenomenon of many transformed cells is an increased level of tyrosine phosphorylated cellular proteins as a result of enhanced tyrosine kinase activity. In the melanoma cell line PSM, derived from a malignant melanoma of the ®sh Xiphophorus (Wakamatsu, 1981) , the degree of cellular tyrosine phosphorylation is also very high. However, the 160 kD Xmrk receptor itself and one or several proteins of approximately 90 ± 95 kD are by far the most abundant phosphotyrosine proteins in the tumor cells (Figure 1) . Remarkably, the phosphorylation state of the 90 ± 95 kD proteins decreased in PSM cells that were treated with tyrphostin AG555 (Figure 1 ), an ecient Xmrk speci®c tyrosine kinase inhibitor (Wellbrock et al., submitted) . In a BHK cell line expressing a 165 kD chimeric HER-mrk receptor (BHK Hm cells, Wellbrock et al., 1995) , two proteins of 92 and 94 kD become tyrosine phosphorylated upon receptor activation (Figure 1 ). This was also observed in IL-3-dependent BaF/3 cells stably transfected with HER-mrk (BaF Hm). When treated with EGF, the HER-mrk receptor becomes tyrosine phosphorylated along with a 92 and a 94 kD protein (Figure 1 ). Because the prominent phosphoproteins are in the size range of STAT factors, we reprobed the antiphosphotyrosine detected blot with anti-sera speci®c for STAT1, 3 and 5. This revealed that the tyrosine phosphorylated protein doublets represent the two isoforms of STAT5 a and b (Figure 1, lower (Figure 2a ), was measured 24 h after stimulation. Wild type Ba/F3 cells did not react to EGF. The induced DNA synthesis occurred in a dose dependent manner (Figure 2b ) with a half-maximum response of *2 ng/ml EGF (0.3 nM). Since in these cells activation of HER-mrk induced cell proliferation, indicating that the receptor ®nds all targets needed for an ecient signalling, we chose BaF Hm cells for our further studies.
STAT5 becomes tyrosine phosphorylated in response to HER-mrk activation
Immunoprecipitation of STAT5 from untreated and EGF-stimulated BaF Hm cells con®rmed that activa- Figure 3 ). IL-3-treated cells, for which STAT5 activation is described , served as a positive control. Anti-STAT5 detection con®rmed that in all precipitates the total amount of STAT5 protein was the same (Figure 3 , lower panel). To compare the tyrosine phosphorylation state of the ®sh STAT5 homologue in PSM cells with a Xiphophorus non-melanoma cell line (A2 cells) STAT5 was immunoprecipitated from both cell types. The STAT5 speci®c anti-serum detected equal amounts of the protein in the immunoprecipitates (Figure 3 , lower panel). However, the tyrosine phosphorylation of STAT5 was extremely high in the melanoma cells and only barely detectable in the non melanoma cells (Figure 3 ). Taken together these data show that STAT5 is present in its tyrosine phosphorylated form in melanoma cells and that tyrosine phosphorylation of STAT5 is induced by an activated Xmrk kinase.
Activation of the Xmrk kinase induces nuclear translocation of STAT5 and formation of a speci®c STAT5/DNA complex
In their activated form STAT proteins are able to migrate into the nucleus (Ru-Jamison et al., 1995). We analysed by¯uorescence microscopy if STAT5 phosphorylated through the Xmrk kinase is able to perform this translocation. In unstimulated BaF Hm cells, anti-STAT5 identi®ed the protein distributed equally throughout the cell ( Figure 4a , upper panel). Translocation of STAT5 to the nucleus was detectable after 30 min stimulation with IL-3 as well as with EGF ( Figure 4a ). However, the nuclear¯uorescence in IL-3 stimulated cells was more intense than that in EGF stimulated cells, indicating that the IL-3 receptor was more ecient in STAT5 translocation than the heterologous HER-mrk kinase.
A nuclear anti-STAT5 staining was also found in PSM cells (Figure 4b, upper panel) demonstrating that the tyrosine phosphorylated ®sh STAT5 is preferentially located in the nucleus of the tumor cells. To analyse if this nuclear localization is brought about by the constituitively activated Xmrk kinase, we treated the cells with tyrphostin AG555. This agent was found to eciently inhibit the Xmrk kinase activity (Wellbrock et al., 1998) Immune complexes were separated by SDS ± PAGE (7.5%) and analysed subsequently with anti-ptyr (upper panel) and anti STAT5 (lower panel). BaF Hm cells were either treated with EGF or IL-3 supernatant for 10 min or were left untreated (7) 1994). To investigate if the Xmrk kinase is able to confer DNA binding activity to STAT5, BaF Hm cells were treated with EGF for 10 min and whole cell extracts were prepared. The extracts were incubated with magnetic beads coupled either to a multimerized oligonucleotide containing the STAT5 binding site derived from the b-casein promoter (wt-bCAS; Pallard et al., 1995) or to a multimerized mutated site with a destroyed STAT5 binding element (mu-bCAS). Bound proteins were eluted, separated by SDS ± PAGE and analysed by immunoblotting ®rst with anti-STAT5 and then with anti-phosphotyrosine ( Figure 5 ). The fact that STAT5 was only bound to the wt-bCAS binding matrix, but not to the matrix bearing the mutated site ( Figure , only STAT5b bound to DNA was detectable under these experimental conditions. After stripping the membrane, detection of the blot with anti-phosphotyrosine revealed that DNA bound STAT5 was tyrosine phosphorylated ( Figure 5 , lower panel). Neither STAT1 nor STAT3 bind to the bCAS site in an Xmrk dependent fashion as revealed by the inability of speci®c antibodies to detect factors on the above blot (data not shown). Since STAT5 is strongly tyrosine phosphorylated in the melanoma cell line PSM, we examined the DNA binding ability of STAT5 in whole cell extracts from these cells. Western blot analysis of eluates from wtbCAS and mu-bCAS coupled magnetic beads with anti-STAT5 clearly showed that in whole cell extracts from PSM cells STAT5 speci®cally binds to DNA ( Figure 6 , lane 3) indicating its constitutive activity. In contrast, in whole cell extracts from non tumorous A2 cells ( Figure 6 , lane 4), in which STAT5 is not tyrosine phosphorylated (Figure 3 ), no STAT5 was found to bind the cognate DNA. Reprobing of the blot with anti-phosphotyrosine showed that the DNA-bound STAT5 from PSM cells was tyrosine phosphorylated, whereas no tyrosine phosphorylated protein was detectable in the DNA eluates from A2 cells ( Figure  6 , lower panel). STAT5 activation by the Xmrk kinase leads to speci®c gene induction
Recently it was shown that expression of a dominantnegative STAT5 in IL-3-stimulated Ba/F3 cells speci®cally suppresses the induction of some IL-3-response genes (Mui et al., 1996) . With this approach the genes cis (cytokine inducible SH2-containing protein; Yoshimura et al., 1995) , pim-1 (Selten et al., 1986) and osm (oncostatin M; Zarling et al., 1986; Yoshimura et al., 1996) could be identi®ed as STAT5 speci®c target genes. In order to study the role of STAT5 in the signalling of the Xmrk kinase, we examined by RT ± PCR analysis if the expression of cis, pim-1 and osm is induced in BaF Hm cells upon HERmrk stimulation. For control BaF Hm cells were treated with IL-3 and the expression of the same genes was analysed. As expected, IL-3 stimulation resulted in a rapid increase in expression of all three genes ( Figure 7, left panel) . The activated Xmrk kinase was also able to induce a similar pattern of STAT5 speci®c gene expression in BaF Hm cells (Figure 7 right  panel) . A maximum in expression of pim-1 and osm was reached within 30 min of HER-mrk stimulation, whereas the induction of cis expression slowly increased within 90 min. The fact that the activated HER-mrk receptor induced the expression of STAT5 target genes in BaF Hm cells clearly shows that in these cells the Xmrk kinase is able to mediate complete functional activation of STAT5.
To further investigate if Xmrk induces the expression of STAT5 target genes also in Xiphophorus melanoma cells, we performed Northern blot analysis of PSM cells as well as of melanoma tissue. Sequence comparisons revealed pim-1 as the most suitable possible probe, because it shows a high degree of similarity among mammals. Using human pim-1 as a probe, expression of a 2.6 kb transcript was detected in the melanoma cell line PSM (Figure 8 ). pim-1 was also found to be expressed in melanoma tissue, whereas no expression was found in non-tumorous skin. The detection of pim-1 transcripts in PSM cells as well as in melanoma tissue suggests that expression of this STAT5 target gene is induced by the constitutively activated STAT5 present in the melanoma cells.
In ®sh melanoma high constitutive activity of STAT5 is correlated with malignancy Malignant melanomas of Xiphophorus are characterized by high expression of Xmrk, whereas in benign lesions lower amounts of Xmrk transcripts are detectable (MaÈ ueler et al., 1993) . Another aspect, in which benign and malignant tumors dier is their dierentiation and proliferation state. Benign lesions are made up of highly dierentiated melanoma cells of low proliferative capacity, whereas malignant melanomas consist predominantly of lowly dierentiated, proliferating cells (Vielkind, 1976) . To investigate if the constitutive activity of STAT5 is related to the pathological stage of the melanoma, benign and malignant ®sh melanoma were compared. Analysis of STAT5 expression revealed that in malignant melanoma the amount of STAT5 protein is not higher than in benign lesions (Figure 9a ). STAT5 expression could also be detected in ®n, from which most of the tumors Following ®rst strand cDNA synthesis respective gene fragments were ampli®ed using speci®c primers as described in Materials and methods. Ampli®ed products were separated on 2% agarose gels and stained with ethidiumbromide. RT ± PCR analysis for gapdh was performed as a control originate (Figure 9a ). However, in this tissue, as well as in benign tumors, the protein shows no tyrosine phosphorylation. Contrary to this, the level of STAT5-tyrosine phosphorylation is increased in malignant tumors (Figure 9a ), suggesting a larger number of activated STAT5 molecules in the malignant lesions. To test this hypothesis whole cell extracts from malignant and benign tumor tissue were incubated with wt-bCAS and mu-bCAS and bound STAT5 was analysed. The amount of wt-bCAS bound STAT5 was signi®cantly higher in extracts from malignant melanomas ( Figure 9b , lanes 3 and 4). We conclude from these results that the state of constitutive STAT5 activation in Xiphophorus melanoma is connected to the malignancy of the tumors.
Discussion
For the RTK Xmrk a role in tumor development is suggested by the fact that overexpression of Xmrk leads to the formation of malignant melanoma in Xiphophorus hybrids (Adam et al., 1991 (Adam et al., , 1993 . We therefore addressed the question which intracellular mechanisms are underlying Xmrk oncogenicity. We found that in malignant melanoma of the ®sh Xiphophorus as well as in a melanoma derived cell line, STAT5 is constitutively tyrosine phosphorylated and activated. Moreover, the degree of STAT5 activation was positively correlated with the malignancy of the tumors (Figure 9 ). The ability of the Xmrk kinase to induce STAT5 DNA-binding in heterologous cells and the fact that in Xiphophorus melanoma this receptor is permanently active, suggest that constitutive activity of STAT5 in these tumors is induced by Xmrk. However, the mechanisms by which STATs are activated through receptors with intrinsic protein tyrosine kinase activity are still unclear. A major step in the signalling of a RTK is the creation of phosphotyrosine-based docking sites for signalling proteins in the carboxyterminal part of the receptor molecules, but not much is known about their involvement in interactions with STATs. Deletion of EGFR carboxyterminal tyrosine residues that conform to the consensus YXXQ led to the loss of STAT activation by this receptor in NIH3T3 cells (Coer and Kruijer, 1995) . On the other hand an EGFR mutant lacking all carboxyterminal tyrosine phosphorylation sites is still able to induce tyrosine phosphorylation and DNA binding of STAT1, 3 and 5 in NR6 ®broblasts (David et al., 1996) . Therefore, although Xmrk is permanently tyrosine phosphorylated in PSM cells and thus might provide substrate docking sites, phospho- tyrosines may not be required for STAT activation by RTKs of the EGFR family. One factor that seems to be essential for STAT activation by RTKs is an intact kinase domain, since a kinase de®cient EGFR mutant fails to stimulate DNA binding of STATs (Leaman et al., 1996; David et al., 1996) . Inhibition of Xmrk by the tyrosine kinase inhibitor AG555 resulted in a loss of constitutive STAT5 tyrosine phosphorylation in ®sh melanoma cells, indicating that this phosphorylation is depent on an active Xmrk kinase either in a direct or indirect way. For cytokine receptors (like the prolactin, IL-3, GM-CSF and Epo receptor), which do not possess a tyrosine kinase domain, members of the family of janus kinases (JAKs) are essential for STAT tyrosine phosphorylation and activation Mui et al., 1995; Quelle et al., 1996) . However, although RTKs are able to activate JAKs, they do not require them for the induction of the STAT pathway. This was shown not only for the EGFR (Leaman et al., 1996; David et al., 1996) , but also for the PDGF receptor (Vignais et al., 1996) . Since the kinase domain of the oncogenic Xmrk receptor is permanently active, it could directly phosphorylate STAT5, leading to a constitutively activated STAT factor in melanoma cells.
The activity of STAT5 is regulated at multiple levels and not only by tyrosine phosphorylation. In erythroid cells, for instance, stimulation of the avian EGFR leads to STAT5 speci®c reporter gene expression, whereas activation of the EpoR in these cells causes speci®c DNA-binding of STAT5, but fails to induce transactivation of respective reporter genes (Mellitzer et al., 1996) . One further regulatory event, for example, is serine phosphorylation, which was shown to be necessary for transactivation (Beadling et al., 1996) . Therefore complete activation of STAT5 is thought to be mediated via dierent pathways. In order to evaluate the physiological relevance of STAT5 activation by the Xmrk kinase, we determined if the HERmrk receptor upon stimulation induces the complete spectrum of STAT5 activities including its contribution to speci®c transcription. In BaF Hm cells, the activated Xmrk kinase induced the expression of the genes cis, osm and pim-1. Since these genes were identi®ed as STAT5 target genes in Ba/F3 cells (Mui et al., 1996; Quelle et al., 1996; Wang et al., 1996) their induction clearly demonstrates the capability of Xmrk to fully activate STAT5. The detection of pim-1 expression in Xiphophorus melanoma points to an analogous situation as in the BaF Hm cells. We conclude that the Xmrk receptor is triggering all signalling pathways required for full STAT5 function in melanoma cells. We do not yet know, how STAT5 activation is related to other signalling events mediated by Xmrk. Besides other interactions Xmrk associates with GRB2, and thus activates the MAP kinase pathway (data not shown). This could result in the serine phosphorylation of STAT5, necessary for its activation. However, if MAP serine kinases are indeed involved in STAT activation is still a matter of debate (David et al., 1995; Beadling et al., 1996) .
The role of the STAT5 target genes osm, cis and pim-1 in cell function is still under investigation. Oncostatin M (osm) is a multifunctional cytokine that inhibits growth of a wide range of tumor cell lines and is produced by activated monocytes and T lymphocytes (Zarling et al., 1986) . cis encodes a 37 kD protein that contains a SH2 domain, which is capable to bind to phosphorylated cytokine receptors (Yoshimura et al., 1996) . The pim-1 gene was originally identi®ed as a common locus of retroviral insertion in Moloney murine leukemia virus (MuLV)-induced T cell lymphomas (Selten et al., 1986) . The gene encodes a serine/ threonine kinase (Saris et al., 1991; Hoover et al., 1991) and is transcribed primarily in hematopoietic tissues. In addition expression is found in cells with high proliferative activity, e.g. cells of the reproductive and the intestinal system (Domen et al., 1993; Stewart and Rice, 1995) . The induction of pim-1 correlates positively with mitogenesis, since its expression was found to be proportional to the proliferative eect of cytokines like IL-3 and GM-CSF in several cell systems (Lilly et al., 1992) Moreover, in c-myc transgenic mice cooperation of c-myc with pim-1 leads to lymphomagenesis (van Lohuizen et al., 1991) . The fact that pim-1 is also expressed in Xiphophorus melanoma tisssue suggests a possible role for this kinase in ®sh melanoma development.
We have found that the activated Xmrk kinase can trigger proliferation of transfected murine BaF Hm cells. This is in agreement with our previous work demonstrating the transformation of NIH3T3 cells by an activated HER-mrk receptor (Wittbrodt et al., 1992) . Although a variety of studies attempted to de®ne the role of STAT5 in cell growth and dierentiation, its requirement for such processes is still a subject of dispute. Some data describe an implication of STAT5 in the control of proliferation (Damen et al., 1995; Friedmann et al., 1996; Mellitzer et al., 1996) , whereas others show that receptor mutants lacking the ability to activate STAT5 are still able to transduce mitogenic signals (Quelle et al., 1996; Fujii et al., 1995) . Moreover, while a dominant negative STAT5 protein was found to inhibit IL-3 driven DNA synthesis in Ba/F3 cells (Mui et al., 1996) , the expression of another dominant negative STAT5 had no eect on IL3-induced proliferation in myeloid cells . These diverging ®ndings can be explained by differences in the respective receptor systems and cellular backgrounds. Nevertheless, the fact that in cells from patients with acute as well as HTLV-1 and v-abl induced leukemia STAT5 is constitutively activated (Gouilleux-Gruart et al., 1996; Migone et al., 1995; Danial et al., 1995) suggests that STAT5 activity may contribute to oncogenesis. We could show that the activity of STAT5 was higher in Xmrk-induced malignant melanoma than in benign, indicating that constitutive STAT5 activation is correlated with the malignancy of the tumors. Malignant melanomas are characterized by undierentiated, but highly proliferating cells, whereas benign tumors consist of highly dierentiated cells with low proliferative capacity. Interestingly tyrphostin AG555, which blocks STAT5 nuclear localization in PSM cells also leads to an inhibition of DNA-synthesis and cellular growth of these Xiphophorus melanoma cells (Wellbrock et al., 1998) . This growth inhibition is accompanied by a morphological change of the cells (data not shown). Therefore, in Xiphophorus melanoma STAT5 activity may be positively connected to proliferation, but negatively to dierentiation. Interestingly, in an erythroleukemia cell line in which Epo-induced proliferation was strictly correlated with STAT5 activation, uncoupling Epo receptor signalling from STAT5 activation led to dierentiation of the cells . On the other hand, STAT5 clearly plays a role in the terminal dierentiation of the mammary gland, since STAT5a knock-out mice are impaired in this process (Liu et al., 1997) . Similarily, interferon treatment of promonocytic U937 cells caused activation of STAT5a and induced differentiation but not proliferation , indicating its involvement in dierentiation control in these cells.
With the current inavailibility to produce knock-out ®sh the biological meaning of constitutive STAT5 activation by Xmrk in melanoma remains unsolved. STAT5 may be used by Xmrk to in¯uence physiological processes, such as dierentiation, proliferation or apoptosis of melanocytes, which ®nally results in manifestation of tumors. Future genetic approaches in transgenic ®sh should help to de®nitively de®ne the role of STAT5 in Xmrk-mediated tumorgenesis.
Materials and methods
Antibodies
5E.2 (anti-ptyr) is a mouse monoclonal antibody directed against phosphotyrosine (Fendly et al., 1990 ) and was kindly provided by A Ullrich. Anti-STAT5b (C-17, Santa Cruz) is a polyclonal rabbit anti-serum, recognising the amino acid sequence 711 ± 727 of STAT5b, but is crossreacting also with STAT5a.
Cells
PSM ®sh melanoma cells (Wakamatsu, 1981) expressing high amounts of endogenous Xmrk and Xiphophorus A2 embryonic cells (Kuhn et al., 1979) were cultured at 288C in F12 medium (Gibco BRL, Germany) containing 10% FCS. BHK Hm cells (Wellbrock et al., 1995) were grown in DMEM/F12 (1 : 1, Gibco BRL) with 10% FCS. The IL-3-dependent mouse pro-B-cell line Ba/F3 (Palacios and Steinmetz, 1985) was cultured in RPMI 1640, with 5% FCS and 5% of supernatant from X63Ag8-653 BVP m-IL-3 expressing cells (Karasuyama and Melchers, 1988) . BaF Hm transfectants were generated by electroporation (Easyject, Eurogentec, 200 V, 1800 mF) of BaF/3 cells with a HER-mrkexpression plasmid driven by the CMV promoter (Prk5HER-mrk) and a hygromycin resistant plasmid (tgCMV/HyTK). After 10 days in medium containing hygromycin B (1 mg/ml), resistant clones were selected and tested for receptor expression on a Western blot. Before stimulation with EGF or IL-3, the cells were washed twice with PBS and starved for 6 h in RPMI. Starved cells were treated with IL-3 (5% sup.) or EGF (50 ng/ml) for the indicated times and collected by centrifugation.
Immunoprecipitations and Western blotting
After stimulation, cells were rinsed twice with cold PBS and lysed in Triton lysis buer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 10% glycerol, 1% Triton X-100, 1 mM PMSF, 1 mM Na 3 VO 4 , 100 mM NaF, 10 mg/ml leupeptin, 10 mg/ml aprotinin) for 20 min at 48C. Lysates of Xiphophorus melanoma biopsies were obtained by extraction of soluble proteins with Triton lysis buer. To remove insoluble material lysates were centrifuged at 48C for 20 min at 10 000 g. The protein concentration in the clear supernatants was determined according to the method of Bradford and 2 mg total protein was used for immunoprecipitation. To the lysates 1 volume of HNTG-buer (20 mM HEPES, pH 7.5, 150 mM NaCl, 10% glycerol, 0.1% Triton X-100, 1 mM Na 3 VO 4 ) was added, followed by an incubation with the indicated antibodies and protein A-Sepharose (20 ml 1 : 1 suspension in HNTG) for at least 2 h at 48C. After precipitation Sepharose pellets were washed three times with 1 ml HNTG-buer, boiled for 5 min in loading buer and separated by SDS ± PAGE (7.5%). The separated proteins were transferred to nitrocellulose using standard Western blotting protocols. Filters were blocked for 5 min with 10 mM Tris-Cl, pH 7.9, 0.5% Tween, 3% BSA and were incubated at least for 90 min with the ®rst antibody. Horseradish peroxidase coupled second antibodies were used for non-radioactive detection (ECL, Amersham). To reprobe Western blots with dierent antibodies, the membrane was stripped in 62.5 mM Tris-Cl, pH 6.7, 2% SDS, 100 mM 2-mercaptoethanol for 30 min at 508C. To remove any remaining SDS the ®lter was washed three times with PBS and blocked again.
Immuno¯uorescence microscopy
10
5 untreated or stimulated BaF Hm cells (see above) were suspended in 500 ml of ice-cold PBS and spun onto slides at 220 g for 3 min using a cytospin device (Hettich). PSM cells were grown on glass coverslips. For tyrphostin treatment 125 mM AG555 in DMSO or DMSO alone was added to the cells for 3 h. After removal of the liquid, cells were consecutively ®xed for 10 min at 7208C in methanol and for 2 min at 7208C in acetone. The ®xed cells were then blocked with 1% BSA in PBS for 20 min at room temperature, washed three times with PBS and incubated with anti-STAT5 serum (5 mg/ml) for 60 min. After washing another incubation with dichlorotriazinamino¯uorescin (DTAF)-conjugated anti-rabbit IgG (Dianova; 30 mg/ml) for 60 min followed. Before embedding the cells were stained for 3 min with Hoechst No 33258 (10 mg/ml in PBS).
Preparation of cell extracts and STAT5 DNA-binding
Whole-cell extracts were prepared from 3610 7 cells by suspending cell pellets in 100 ml of low salt lysis buer (20 mM HEPES, pH 7.9, 20% glycerol, 100 mM NaCl, 50 mM KCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 1 mM Na 3 VO 4 , 10 mg/ml leupeptin, 10 mg/ml aprotinin). After three freeze-thaw cycles lysates were centrifuged at 48C for 30 min at 10 000 g. The whole cleared supernatant was then incubated with 100 mg of M280-Streptavidin Dynabeads (Dynal) carrying either the STAT5 bCAS bindingsite (5'-GATCAGATTTCTAGGAATTCAATCC-3'; Pallard et al., 1995) derived from the bovine b-casein promoter or a mutated sequence (5'-GATCAGATT-TATTTTAATTCAATCC-3'), which does not possess the STAT5 binding motif 5'-TTCXXXGAA-3'. Double stranded oligonucleotides were end biotinylated and coupled to Dynabeads according to the manufacturer's instructions. Incubation was for 1 h at room temperature followed by three times washing with low salt buer (50 mM NaAc, pH 7.5, 50 mM NaCl) and elution of the bound protein(s) with 10 ml elution buer (50 mM NaAc, pH 7.5, 1 M NaCl). 10 ml of 26SDS-loading buer was added and the eluates were analysed on a Western blot.
RT ± PCR analysis
After stimulation, cells were rinsed twice with cold PBS, and RNA was isolated with RNeasy columns (Qiagen). First strand cDNA synthesis was performed by using SUPERSCRIPT RT reverse transcriptase (Gibco BRL) using 1 mg total RNA and random hexanucleotides (0.5 mM) in 20 ml following the suppliers protocol. 3 ml of each RT-reaction was then used to amplify the respective genes with a number of cycles, where ampli®cation was still linear. The used primers were as follows: for cis 5'-CTG-CTGTGCATAGCCAAGACGTTC-3' and 5'-CAGAGTT-GGAAGGGGTACTGTCGG-3' (25 cycles); for pim-1 5'-ACGTGGAGAAGGACCGGATTTCC-3' and 5'-GATGT-TTTCGTCCTTGATGTCGC-3' (23 cycles); for osm 5'-TG-CTCCTGGAAGGTCTGATTTTGC-3' and 5'-CGGCAC-AATATCCTCGGCATAAGG-3' (30 cycles); for gapdh 5'-CGGAGTCAACGGATTTGGTCGTAT-3' and 5'-AGCC-TTCTCCATGGTGGTGAAGAC-3' (25 cycles).
Northern blot analysis
RNA from Xiphophorus tissues was prepared with TRIZOL reagent (GIBCO-BRL, NY) following the instructions of the supplier. 20 mg of total RNA was blotted onto Hybond-N nylon membranes (Amersham, UK). Prehybridization and hybridization were carried out in 40% formamide at 428C. After hybridization ®lters were washed with 16SSC/1% SDS at 558C for 1 h and exposed. From the EST clone IMAGp998J11687 (Resource Centre, MPI Berlin) a fragment was isolated that contains 0.57 kb of the 3' end of the coding sequence of human pim-1. This fragment was labelled with a 32 P-dCTP by random priming and used as a hybridization probe.
Thymidine incorporation assay
4610
4 cells were seeded per well of a 96-well plate and treated with IL-3 (5% sup.) or EGF (50 ng/ml). After 20 h, 0.5 mCi of 3 H-thymidine per well was added for 4 h and cells were harvested onto glass ®bre ®lters. Incorporated 3 H-thymidine was quantitated by liquid scintillation counting.
